MARKETSSTORY 599· JUNE 21, 2026

Pomerantz LLP Files Class Action Lawsuit Against ADMA Biologics, Alerts Investors to Upcoming Deadline

Pomerantz LLP, the New York-based law firm, has announced the filing of a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA), urging investors who suffered losses on their ADMA positio

NDNewsDialy Desk2 MIN READ

SOURCE

prnewswire.com

← PREVIOUS STORY 598Michael Bloomberg Pledges $285 Million to Renewable Energy Associations in Lobbying Fight Against Oil Interests NEXT STORY 600 →GLP-1 Weight-Loss Drugs Are Reshaping How Brides Shop for Wedding Gowns

Keep reading

More from the desk.

50MARKETS

Nvidia debt-insurance costs hit a record as $750 billion AI financing talks spook bond markets

The cost of a credit-default swap, a debt-insurance contract, climbed to a record for Nvidia (NVDA) this week, following reports the company is in discussions over more than $750 billion in AI infrastructure

markets2 MIN

87MARKETS

Saudi Arabia intercepts Houthi missiles and strikes back in Yemen as Red Sea conflict escalates

Red Sea shipping, the cargo traffic moving through a critical maritime chokepoint linking Europe to Asia, came under attack from Yemen-based fighters. Saudi Arabia intercepted two ballistic

markets2 MIN

88MARKETS

AI distillation goes from research niche to regulatory flashpoint

Distillation, a process that takes the knowledge embedded in a large AI model and transfers it into a smaller, cheaper one, has moved out of research circles and into the center of a live policy fight

markets2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk